dihexa cancer risk hgf c-met targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the receptor, it helps cells take in nutrients and rebuild—especially in cases where recovery is Recent Progress and Advances in
Recent Progress and Advances in HGF MET Targeted Therapeutic Agents for Cancer Treatment Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect HGF MET Signaling in Malignant Brain Tumors
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



